Caprihans India Limited (BOM:509486)

India flag India · Delayed Price · Currency is INR
66.94
-1.07 (-1.57%)
At close: Mar 9, 2026
-51.12%
Market Cap 978.93M
Revenue (ttm) 7.07B
Net Income (ttm) -516.70M
Shares Out 14.62M
EPS (ttm) -35.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,884
Average Volume 5,340
Open 67.21
Previous Close 68.01
Day's Range 65.33 - 70.73
52-Week Range 65.00 - 167.70
Beta 0.20
RSI 24.86
Earnings Date Feb 10, 2026

About Caprihans India

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax, Zymax Tx, and Zymax PDP names; coldforming blister foils under the Venus, Venus PR, Venus SBC, ... [Read more]

Industry Miscellaneous Plastics Products
Founded 1946
Employees 540
Stock Exchange Bombay Stock Exchange
Ticker Symbol 509486
Full Company Profile

Financial Performance

In fiscal year 2025, Caprihans India's revenue was 7.40 billion, an increase of 6.36% compared to the previous year's 6.95 billion. Losses were -621.80 million, 20.5% more than in 2024.

Financial Statements

News

There is no news available yet.